FASENRA
Active substance: benralizumab
INJECTION, SOLUTION · BENRALIZUMAB 10 mg/.5mL
United StatesActive
Marketing holder: AstraZeneca Pharmaceuticals LP
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- BENRALIZUMAB · 10 mg/.5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-9502-7d85-8a3e-cd216986eb95,01a1208d-7179-7969-a099-c3157b97e64a,01a1208f-8223-78eb-a52b-03316756d1fa,01a12092-4328-7970-94e1-32119742acdb;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0310-1745
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0310-1745 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0310-1745 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0310-1745 · Verified 2026-10-09 · open in source